Loading clinical trials...
Loading clinical trials...
Randomized, Age-stratified, Double Blind, Controlled Phase 3 Study Comparing a Vero Cell-derived Trivalent Seasonal Influenza Vaccine Made by the Modified Manufacturing Process With Vaccine Made by the Current Manufacturing Process and a Licensed Trivalent Influenza Vaccine in Healthy Adults Aged 18 Years and Older
Conditions
Interventions
Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified)
VCIV manufactured with the current manufacturing process (VCIV current)
+1 more
Locations
20
United States
East Valley Family Physicians, PLC
Chandler, Arizona, United States
Anaheim Clinical Trials
Anaheim, California, United States
Center for Clinical Trials, LLC
Paramount, California, United States
California Research Foundation
San Diego, California, United States
Benchmark Research San Francisco
San Francisco, California, United States
Clinical Research of South Florida
Coral Gables, Florida, United States
Start Date
January 1, 2013
Primary Completion Date
April 1, 2013
Completion Date
April 1, 2013
Last Updated
September 11, 2025
NCT01386424
NCT07169318
NCT07291635
NCT06599658
NCT06094010
NCT06753474
Lead Sponsor
Alachua Government Services, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions